Neoadjuvant chemotherapy plus tislelizumab followed by concurrent chemoradiotherapy in patients with locoregionally advanced nasopharyngeal carcinoma: A single-arm, phase II trial.

被引：0
|
作者：
Chen, Qiu-Yan
Mai, Hai-Qiang
Tang, Lin-Quan
Luo, Meijuan
Zhao, Chong
Mo, Hao-Yuan
Sun, Rui
Luo, Dong-Hua
Wang, Lin
Guo, Shan-Shan
Xie, Siyi
Li, Su-Chen
Liu, Sai-Lan
Li, Xiao Yun
Peng, Jing-Yun
Qiu, Hui-Zhi
Sun, Xue-Song
Liu, LiTing
机构：
[1] Sun Yat Sen Univ, Canc Ctr, Guangzhou, Peoples R China
[2] Sun Yat Sen Univ, Dept Nasopharyngeal Carcinoma, Canc Ctr, Guangzhou, Peoples R China
[3] Sun Yat Sen Univ, Ctr Canc, Guangzhou, Peoples R China
[4] Sun Yat Sen Univ, Dept Nasopharyngeal Carcinoma, Collaborat Innovat Ctr Canc Med, State Key Lab Oncol South China,Canc Ctr, Guangzhou, Peoples R China
[5] Sun Yat Sen Univ, Guangzhou, Peoples R China
[6] Sun Yat Sen Univ, Dept Nasopharyngeal Carcinoma, Canc Ctr, Guangzhou, Peoples R China
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2022年 / 40卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
6068
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Neoadjuvant camrelizumab plus chemotherapy in patients with locoregionally advanced nasopharyngeal carcinoma: A single-arm, phase II trial
    Gao, Jin
    Qian, Liting
    Zhou, Lingran
    Sun, Bin
    He, Jian
    Wang, Ru
    Zhang, Yangyang
    Yang, Liping
    Zhou, Yan
    Yang, Jing
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [2] Neoadjuvant chemotherapy followed by concurrent chemoradiotherapy versus concurrent chemoradiotherapy alone in locoregionally advanced nasopharyngeal carcinoma: A phase III multicentre randomised controlled trial.
    Chen, Ming-Yuan
    Cao, Su-Mei
    Yang, Qi
    Guo, Ling
    Mai, Hai-Qiang
    Mo, Hao-Yuan
    Cao, Ka-Jia
    Qian, Chao-Nan
    Zhao, Chong
    Yanqun, Xiang
    Zhang, Xiu-Ping
    Lin, Zhi-Xiong
    Li, Wei-Xiong
    Guo, Xiang
    Hong, Ming-Huang
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [3] A phase II trial of neoadjuvant gemcitabine, cisplatin plus tislelizumab followed by concurrent chemoradiotherapy in locoregionally advanced nasopharyngeal carcinoma: Clinical efficacy, safety and the biomarker analysis
    Li, Xiao-Yun
    Xie, Si-Yi
    Chen, Qiu-Yan
    Mai, Hai-Qiang
    Tang, Lin-Quan
    [J]. CANCER RESEARCH, 2024, 84 (06)
  • [4] Neoadjuvant docetaxel-cisplatin followed by concurrent chemoradiotherapy and adjuvant tislelizumab for locally advanced nasopharyngeal carcinoma: A multi-center, single-arm, phase II trial
    Yuan, Yawei
    Tian, Yunhong
    Zhong, Huang
    Zheng, Ronghui
    Jie, Lin
    Zhang, Jian
    Liao, Kai
    Deng, Jin
    Yu, Yi
    Qiu, Wenze
    Bu, Junguo
    Zheng, Rong
    Xu, Benhua
    Chen, Yong
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [5] Tislelizumab plus neoadjuvant chemotherapy and concurrent chemoradiotherapy versus neoadjuvant chemotherapy and concurrent chemoradiotherapy in local advanced nasopharyngeal carcinoma
    Luo, Haiqing
    He, Jiaqi
    Yi, Guihua
    Tang, Haifeng
    Yang, Donghong
    Li, Haiwen
    Yu, Ying
    Chen, Zihong
    Zhan, Dechao
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [6] Neoadjuvant chemoradiotherapy plus tislelizumab followed by surgery for esophageal carcinoma (CRISEC study): the protocol of a prospective, single-arm, phase II trial
    Yang, Jinsong
    Huang, Ai
    Yang, Kunyu
    Jiang, Ke
    [J]. BMC CANCER, 2023, 23 (01)
  • [7] Neoadjuvant chemoradiotherapy plus tislelizumab followed by surgery for esophageal carcinoma (CRISEC study): the protocol of a prospective, single-arm, phase II trial
    Jinsong Yang
    Ai Huang
    Kunyu Yang
    Ke Jiang
    [J]. BMC Cancer, 23
  • [8] Tislelizumab plus chemotherapy as induction treatment followed by chemoradiotherapy or surgery in locally advanced hypopharyngeal squamous cell carcinoma: A single-arm, phase II trial
    Gui, Lin
    Liu, Shaoyan
    Wang, Xiaolei
    Zhang, Ye
    He, Xiaohui
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [9] Tislelizumab plus neoadjuvant chemotherapy and concurrent chemoradiotherapy versus neoadjuvant chemotherapy and concurrent chemoradiotherapy for locally advanced nasopharyngeal carcinoma: A retrospective study
    He, Jiaqi
    Luo, Guoqing
    Liu, Shen
    Chen, Lingli
    Chen, Zihong
    Zhang, Bing
    Lin, Jiong
    Qin, Wenyi
    Li, Haiwen
    Zhou, Haideng
    Yu, Ying
    Zhan, Dechao
    Yang, Donghong
    Luo, Haiqing
    [J]. TRANSLATIONAL ONCOLOGY, 2024, 48
  • [10] Neoadjuvant chemotherapy followed by concurrent chemoradiotherapy versus concurrent chemoradiotherapy alone in locoregionally advanced nasopharyngeal carcinoma: A phase III multicentre randomised controlled trial
    Cao, Su-Mei
    Yang, Qi
    Guo, Ling
    Mai, Hai-Qiang
    Mo, Hao-Yuan
    Cao, Ka-Jia
    Qian, Chao-Nan
    Zhao, Chong
    Xiang, Yan-Qun
    Zhang, Xiu-Ping
    Lin, Zhi-Xiong
    Li, Wei-Xiong
    Liu, Qing
    Qiu, Fang
    Sun, Rui
    Chen, Qiu-Yan
    Huang, Pei-Yu
    Luo, Dong-Hua
    Hua, Yi-Jun
    Wu, Yi-Shan
    Lv, Xing
    Wang, Lin
    Xia, Wei-Xiong
    Tang, Lin-Quan
    Ye, Yan-Fang
    Chen, Ming-Yuan
    Guo, Xiang
    Hong, Ming-Huang
    [J]. EUROPEAN JOURNAL OF CANCER, 2017, 75 : 14 - 23
12345